The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Open accessAbstract
F 2 -Isoprostanes are prostaglandin (PG) isomers formed in situ in cell membranes by peroxidation of arachidonic acid.8-epi PGF 2 ␣ and IPF 2 ␣ -I are F 2 -isoprostanes produced in humans which circulate in plasma and are excreted in urine.Measurement of F 2 -isoprostanes may offer a sensitive, specific, and noninvasive method for measuring oxidant stress in clinical settings where reactive oxygen species are putatively involved.We determined whether isoprostanes were present in human atherosclerotic lesions, where lipid peroxidation is thought to occur in vivo.8-epi PGF 2 ␣ ranged from 1.310-3.450pmol/ mol phospholipid in atherectomy specimens compared with 0.045-0.115pmol/ mol phospholipid ( P Ͻ 0.001) in vascular tissue devoid of atherosclerosis.Corresponding values of IPF 2 ␣ -I were 5.6-13.8 vs. 0.16-0.44pmol/ mol phospholipid ( P Ͻ 0.001).Levels of the two isoprostanes in vascular tissue were highly correlated ( r ϭ 0.80, P Ͻ 0.0001).Immunohistochemical studies confirmed that foam cells adjacent to the lipid necrotic core of the plaque were markedly positive for 8-epi PGF 2 ␣ .These cells were also reactive with anti-CD68, an epitope specific for human monocyte/macrophages. 8-epi PGF 2 ␣ immunoreactivity was also detected in cells positive for anti-␣ -smooth muscle actin antibody, which specifically recognizes vascular smooth muscle cells.Our results indicate that 8-epi PGF 2 ␣ and IPF 2 ␣ -I, two distinct F 2 -isoprostanes and markers of oxidative stress in vivo, are present in human atherosclerotic plaque.Quantitation of these chemically stable products of lipid peroxidation in target tissues, as well as in biological fluids, may aid in the rational development of antioxidant drugs in humans.( J. Clin.Invest.1997.100:2028-2034.)Key words: atherosclerosis • oxidative stress • lipid peroxidation • isoprostanes Methods Sample acquisition and tissue processing.Human atherosclerotic plaques were obtained from 12 patients undergoing carotid endarterectomy.Informed consent was obtained from all patients before surgery.All procedures were approved by the local human ethics committee.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., & Steinberg, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,880
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
The oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
The measurement and mechanism of lipid peroxidation in biological systems
Gutteridge, J. M. C., & Halliwell, B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,283
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., & Fogelman, A. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114562 · Cited by 925
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Self-citationHeinecke, J. W., Rosen, H., & Chait, A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111609 · Cited by 536
Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 511
Brown, D. L., Hibbs, M. S., Kearney, M., Loushin, C., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.8.2125 · Cited by 487
Sparrow, C. P., Parthasarathy, S., & Steinberg, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81655-1 · Cited by 475
Rosenfeld, M. E., Palinski, W., Ylä-Herttuala, S., Butler, S., & Witztum, J. L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.3.336 · Cited by 474
Pulford, K. A., Rigney, E. M., Micklem, K. J., Jones, M., Stross, W. P., Gatter, K. C., & Mason, D. Y. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.4.414 · Cited by 466
Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II
Rohrer, L., Freeman, M., Kodama, T., Penman, M., & Krieger, M. (1990) · Nature · doi:10.1038/343570a0 · Cited by 457
A fast, simple and reliable method for the microdetermination of phosphorus in biological materials
Morrison, W. R. (1964) · Analytical Biochemistry · doi:10.1016/0003-2697(64)90231-3 · Cited by 372
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
Wang, Z., Ciabattoni, G., Créminon, C., Lawson, J., Fitzgerald, G. A., Patrono, C., & Maclouf, J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12087-9 · Cited by 341
Self-citationMorrow, J. D., Awad, J. A., Kato, T., Takahashi, K., Badr, K. F., Roberts, L. J., & Burk, R. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116143 · Cited by 319
Knox, J. B., Sukhova, G. K., Whittemore, A. D., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.95.1.205 · Cited by 311
Delanty, N., Reilly, M. P., Pratico, D., Lawson, J. A., McCarthy, J. F., Wood, A. E., Ohnishi, S. T., Fitzgerald, D. J., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.95.11.2492 · Cited by 267
Self-citationCylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
Self-citationMalondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
Holvoet, P., Perez, G., Zhao, Z., Brouwers, E., Bernar, H., & Collen, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117963 · Cited by 262
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells
Fukunaga, M., Makita, N., Roberts, L. J., Morrow, J. D., Takahashi, K., & Badr, K. F. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1619 · Cited by 254
Lynch, S. M., Morrow, J. D., Roberts, L. J., & Frei, B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117107 · Cited by 236
Morrow, J. D., & Jackson Roberts, L. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33019-0 · Cited by 224
Reilly, M. P., Delanty, N., Roy, L., Rokach, J., Callaghan, P. O., Crean, P., Lawson, J. A., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3314 · Cited by 210
Self-citationPraticò, D., Smyth, E. M., Violi, F., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14916 · Cited by 204
Self-citationYlä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Goldberg, I. J., Steinberg, D., & Witztum, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10143 · Cited by 196
Generation of 8-Epiprostaglandin F by Human Monocytes
Praticó, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 187
Self-citationOxidative DNA damage correlates with oxygen consumption in humans
Loft, S., Astrup, A., Buemann, B., & Poulsen, H. E. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.8.8181672 · Cited by 180
Aspects to Consider When Detecting and Measuring Lipid Peroxidation
Gutteridge, J. M. C. (1986) · Free Radical Research Communications · doi:10.3109/10715768609083149 · Cited by 171
Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivo
Morrow, J. D., Minton, T. A., Badr, K. F., & Roberts, L. J. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90128-7 · Cited by 164
Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · PubMed · Cited by 160
Self-citationLipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein.
Lenz, M. L., Hughes, H., Mitchell, J. R., Via, D. P., Guyton, J., Taylor, A. A., Gotto, A. M., & Smith, C. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42744-0 · Cited by 153
Arai, H., Kita, T., Yokode, M., Narumiya, S., & Kawai, C. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92262-6 · Cited by 149
荒井, 秀. (1991) · Medical Entomology and Zoology · doi:10.11501/3052959 · Cited by 144
Bolli, R., Zughaib, M., Li, X. Y., Tang, X., Sun, J. Z., Triana, J. F., & McCay, P. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118093 · Cited by 135
Mildly Oxidized LDL Induces Platelet Aggregation Through Activation of Phospholipase A2
Weidtmann, A., Scheithe, R., Hrboticky, N., Pietsch, A., Lorenz, R. L., & Siess, W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1131 · Cited by 133
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ
Banerjee, M. R., Kang, K. H., Morrow, J. D., Roberts, L. J., & Newman, J. H. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.3.h660 · Cited by 125
O'Connor, D. E., Mihelich, E. D., & Coleman, M. C. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00324a028 · Cited by 124
Weis, J. R., Pitas, R. E., Wilson, B. D., & Rodgers, G. M. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.10.2065893 · Cited by 110
Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo.
Lehr, H., Becker, M., Marklund, S. L., et al. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.7.824 · Cited by 76
Patrignani, P., Santini, G., Panara, M. R., Sciulli, M. G., Greco, A., Rotondo, M. T., di Giamberardino, M., Maclouf, J., Ciabattoni, G., & Patrono, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15535.x · Cited by 75
Self-citationMehta, A., Yang, B., Khan, S. R., Hendricks, J. B., Stephen, C. A., & Mehta, J. L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.2076 · Cited by 61
Total synthesis of a novel isoprostane IPF2α-I and its identification in biological fluids
Adiyaman, M., Lawson, J. A., Hwang, S., Khanapure, S. P., FitzGerald, G. A., & Rokach, J. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)00973-2 · Cited by 55
Self-citationLi, Q., & Cathcart, M. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32470-5 · Cited by 51
Oxidation-Related Analytes and Lipid and Lipoprotein Concentrations in Healthy Subjects
Craig, W. Y., Poulin, S. E., Palomaki, G. E., Neveux, L. M., Ritchie, R. F., & Ledue, T. B. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.733 · Cited by 50
Chen, M.-F., Hsu, H., & Lee, Y. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90016-7 · Cited by 28
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Antioxidants and Prevention of Chronic Disease
WILLCOX, J. K., ASH, S. L., & CATIGNANI, G. L. (2004) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690490468489 · Cited by 1,188
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
Roberts, L. J., & Morrow, J. D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00264-6 · Cited by 996
Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093660.86242.bb · Cited by 941
Self-citation
Metadata
- Authors
- Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-10-15
- Volume
- 100
- Issue
- 8
- Pages
- 2028-2034
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2033539598
- Cited by
- 344
- References
- 52
- FWCI
- 14.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.